Literature DB >> 8210074

Clinical relevance of IgG subclass deficiencies.

A Morell1.   

Abstract

Patients with primary or secondary IgG subclass deficiencies suffer from infections due to encapsulated microorganisms such as H influenzae and pneumococci. In addition to relapsing infections, some patients with primary subclass deficiencies may have autoimmune disorders. The best characterized defect in IgG2 deficiency, either isolated or combined with IgG4 deficiency. It is frequently associated with IgA deficiency or with ataxia telangiectasia. IgG1 deficiency occurs mostly in combination with disturbances of other immunoglobulin isotypes, and probably represents a form of common variable immune deficiency. Decreased IgG3 levels were reported in association with lung dysfunction and viral diseases. Except in IgG1 deficiency, total IgG serum levels in primary as well as secondary IgG subclass deficiency states may be normal or even increased. It is assumed that IgG subclass deficiencies represent an indicator of more basic immunologic abnormalities. There is evidence that antibody defects correlate better with the clinical symptoms than the total serum IgG subclass concentrations. In patients with severe recurrent infections and IgG subclass deficiency, intravenous immunoglobulin treatment at dosages of 0.3 to 0.4 g/kg body weight every 3-4 weeks is indicated.

Entities:  

Mesh:

Year:  1994        PMID: 8210074

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  6 in total

1.  Defective anti-polysaccharide IgG vaccine responses in IgA deficient mice.

Authors:  Yoichi Furuya; Girish S Kirimanjeswara; Sean Roberts; Rachael Racine; Jennifer Wilson-Welder; Alan M Sanfilippo; Sharon L Salmon; Dennis W Metzger
Journal:  Vaccine       Date:  2017-07-31       Impact factor: 3.641

2.  Immunoglobulin dosage and switch from intravenous to subcutaneous immunoglobulin replacement therapy in patients with primary hypogammaglobulinemia: decreasing dosage does not alter serum IgG levels.

Authors:  Sylvain Thépot; Marion Malphettes; Anaëlle Gardeur; Lionel Galicier; Bouchra Asli; Lionel Karlin; Laurence Gérard; Richard Laumont; Marie-Laure Doize; Bertrand Arnulf; Claire Fieschi; Djaouïda Bengoufa; Eric Oksenhendler
Journal:  J Clin Immunol       Date:  2010-07       Impact factor: 8.317

3.  Differential diagnosis of lupus and primary membranous nephropathies by IgG subclass analysis.

Authors:  Young Soo Song; Kyueng-Whan Min; Ju Han Kim; Gheun-Ho Kim; Moon Hyang Park
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-27       Impact factor: 8.237

4.  TNFRSF13B/TACI alterations in Greek patients with antibody deficiencies.

Authors:  Matthaios Speletas; Antigoni Mamara; Efimia Papadopoulou-Alataki; George Iordanakis; Kyriaki Liadaki; Fotini Bardaka; Maria Kanariou; Anastasios E Germenis
Journal:  J Clin Immunol       Date:  2011-05-06       Impact factor: 8.317

5.  An Alteration of Lymphocytes Subpopulations and Immunoglobulins Levels in Patients with Diabetic Foot Ulcers Infected Particularly by Resistant Pathogens.

Authors:  Vladimíra Fejfarová; Alexandra Jirkovská; Michal Dubský; Frances Game; Jana Vydláková; Alena Sekerková; Jana Franeková; Monika Kučerová; Ilja Stříž; Vladimír Petkov; Robert Bém; Veronika Wosková; Andrea Němcová; Jelena Skibová
Journal:  J Diabetes Res       Date:  2016-12-05       Impact factor: 4.011

6.  Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42.

Authors:  Georg Rüdiger Schramm; Behrouz Mostafavi; Eeva Piitulainen; Per Wollmer; Hanan A Tanash
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-12-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.